Is Trazodone Safe for Sleep?
Trazodone is one of the most commonly prescribed sleep aids in the U.S. — but it's technically an antidepressant, and its safety for long-term sleep use warrants close examination.
Trazodone is generally considered safe for sleep when used at lower sub-antidepressant levels under medical supervision. It is not habit-forming in the way that benzodiazepines or Z-drugs (like Ambien) are. However, it can cause significant next-day drowsiness, low blood pressure, and — rarely — serious cardiac and hormonal side effects. Long-term use for sleep has limited formal study data compared to its antidepressant use.
What Is Trazodone?
Trazodone is an antidepressant classified as a serotonin antagonist and reuptake inhibitor (SARI). Originally developed and approved to treat major depressive disorder, it has become one of the most widely prescribed sleep aids in the United States — despite this use being off-label. Its sedating properties at lower levels make it attractive to prescribers looking for a non-controlled sleep aid.
Trazodone is available in immediate-release tablets in various strengths. At lower levels it is primarily sedating; at full antidepressant levels it treats depression. This profile has made it uniquely useful for patients with both depression and insomnia.
Why Is Trazodone Used for Sleep?
Trazodone's sleep-promoting effects come from its antihistaminic and alpha-1 adrenergic blocking properties, both of which cause sedation. Unlike benzodiazepines, trazodone does not bind to GABA receptors, which means it does not carry the same risk of physical dependence, tolerance, and rebound insomnia associated with those drugs.
From a prescriber's perspective, trazodone for sleep is appealing because:
- It is not a controlled substance
- It is inexpensive as a generic
- It is not associated with the abuse potential of sedative-hypnotics
- It may simultaneously help with underlying depression or anxiety driving the insomnia
Safety Profile for Sleep Use
At the sub-antidepressant levels typically used for sleep, trazodone is generally well tolerated. Studies of its use specifically for insomnia support short-term efficacy and a reasonable safety profile. Common side effects include:
- Next-day sedation: Residual grogginess in the morning is one of the most common complaints, especially early in treatment or if taken too late.
- Dizziness: Particularly upon standing (orthostatic hypotension — a drop in blood pressure when rising). This raises fall risk in elderly patients.
- Dry mouth
- Blurred vision
- Headache
- Nausea
Serious but Rare Risks
Other serious but uncommon risks include:
- Cardiac arrhythmias: Trazodone can affect the QT interval on an electrocardiogram, potentially triggering abnormal heart rhythms in susceptible individuals. People with pre-existing heart disease or those taking other QT-prolonging drugs require particular caution.
- Serotonin syndrome: When combined with other serotonergic drugs (other antidepressants, MAOIs, certain pain medications), trazodone can contribute to excess serotonin activity. While less common at sleep doses, the risk exists and drug interactions must be carefully reviewed.
- Hyponatremia: Low sodium in the blood, particularly in elderly patients, has been associated with antidepressant use including trazodone.
Who Should Be Cautious?
- Elderly patients: More vulnerable to orthostatic hypotension, falls, cognitive effects, and hyponatremia. Trazodone appears on the Beers Criteria list of medications to use with caution in older adults.
- People with heart disease: Due to QT-prolonging effects and cardiac rhythm concerns.
- Anyone taking MAO inhibitors: Serious and potentially fatal drug interaction.
- People taking other QT-prolonging medications: Increased arrhythmia risk.
- Pregnant individuals: Safety in pregnancy is not fully established; discuss with an OB-GYN.
Long-Term Considerations
There is less data on long-term trazodone use specifically for insomnia compared to its antidepressant use. While it is not physically addictive, psychological reliance is possible, and the underlying cause of insomnia may remain unaddressed. Cognitive behavioral therapy for insomnia (CBT-I) remains the most effective long-term solution for chronic insomnia and should be explored alongside or instead of medication.
Need to identify a pill?
Use the Free PillID Identifier →Frequently Asked Questions
Trazodone is not considered habit-forming or physically addictive in the traditional sense. It does not carry the dependence or controlled-substance concerns of benzodiazepines or Z-drugs. However, some people experience mild discontinuation symptoms when stopping abruptly, and psychological reliance on it for sleep is possible. Tapering gradually under medical guidance is recommended after long-term use.
Yes. Next-day sedation (sometimes called a "hangover effect") is a common complaint with trazodone, particularly at higher amounts or when taken too late at night. Taking it earlier in the evening and allowing 7–8 hours before waking can help minimize this effect.
Trazodone is generally considered safer than benzodiazepines (like temazepam) and Z-drugs (like zolpidem/Ambien) for sleep, particularly for long-term use, because it lacks significant dependence potential and controlled-substance status. However, "safer" is relative — trazodone still has its own side effect profile and risks that vary by individual.